Skip to main content
Influenza and Other Respiratory Viruses logoLink to Influenza and Other Respiratory Viruses
. 2010 Oct 1;4(6):357–361. doi: 10.1111/j.1750-2659.2010.00162.x

Infectivity of equine H3N8 influenza virus in bovine cells and calves

Chengbin Lin , Robert E Holland Jr , Morgan H McCoy §, Jennifer Donofrio‐Newman ||, Mary L Vickers 1, Thomas M Chambers 1
PMCID: PMC4634616  PMID: 20976994

Abstract

Please cite this paper as: Lin et al. (2010) Infectivity of equine H3N8 influenza virus in bovine cells and calves. Influenza and Other Respiratory Viruses 4(6), 357–361.

Background  Serological evidence for influenza A, subtype H1 and H3 virus infections of bovines, associated with respiratory disease and decreased milk production, has been reported. Equine H3N8 influenza virus circulates widely and was responsible for the introduction of H3N8 influenza into canines.

Objective  To explore the possibility that equine H3N8 influenza might also infect bovines.

Methods  To assess the incidence of seroconversion in the field, a retrospective survey of bovine serum samples was carried out. Also, primary cultures of bovine nasal turbinate cells, and live beef calves, were studied for their permissiveness to infection.

Results and Conclusions  We found serological evidence of exposure of bovines in Kentucky to H3 influenza. We demonstrate that cultured bovine respiratory epithelium is permissive for the growth of equine H3N8 influenza virus in vitro, but this virus does not replicate extensively or produce disease in experimentally inoculated cattle.

Keywords: Cattle, epithelium, host range, temperature‐sensitive


Cows and steers are not commonly recognized as natural hosts for influenza viruses. However, a number of reports suggest sporadic transmission of influenza to ruminants. Significant incidence of cattle seropositive to influenza A viruses of the H1 and H3 subtypes has been reported, 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 and this has been associated with decreased milk production and sometimes respiratory diseases. 1 , 3 , 4 However, no influenza virus was isolated in those studies. Cattle can be experimentally infected with human and swine influenza A viruses 9 , 10 as well as with pandemic H5N1 avian influenza virus, 11 although generally without overt signs of disease.

Horses are a natural host to influenza A virus. Equine H3N8 influenza viruses actively circulate in horses in much of the world. 12 Equine H3N8 virus also is transmitted across species barriers into canines and since 2004 has established itself in canine populations in the USA. 13 The potential of equine influenza virus (EIV) as a source of respiratory disease in cattle and the cellular pathology of EIV infection in bovines are not clear. As cows and horses sometimes come into proximity, it was of interest to determine whether bovines are susceptible to EIV infection.

Survey of random bovine sera for HI antibodies to H3 influenza

To add the bovine sero‐epidemiological picture in Kentucky to that previously published for Minnesota 5 and the United Kingdom, 1 , 3 , 4 , 8 we performed a retrospective serological survey of random stored bovine serum samples submitted in 1999 and 2000 for routine diagnostics at the University of Kentucky Livestock Disease Diagnostic Center. Samples were Kaolin‐treated sera from Kentucky cattle of various breeds from ages 4 months to 8 years. When measured by hemagglutination‐inhibition assay using chicken erythrocytes, 14 51% of sera had detectable antibodies to either influenza A/equine/Kentucky/94 (H3N8) or influenza A/swine/Texas/98 (H3N2) (Table 1). The two antigens partially cross‐react, and we observed higher incidence and significantly higher titers of positive reactions against the swine strain (P = 0.003). However, there are relatively few swine in Kentucky. Therefore, the source of viruses responsible for seroconversion to H3 influenza in the bovines tested is unclear. We did not test for antibodies against subtype H1 influenza.

Table 1.

 Survey of random bovine sera for HI antibodies to H3 influenza

1999 2000 Total
Number of samples tested 241 111 352
Equine/KY/94
 Number positive 53 (22%) 7 (6%) 60 (17%)
 Mean titer and (range) (pos only) 28 (20–40) 20 (20–20) 28
Swine/TX/98
 Number positive 134 (56%) 44 (40%) 178 (51%)
 Mean titer and (range) (pos only) 43 (20–160) 23 (20–40) 37

Randomly selected, kaolin‐treated sera from Kentucky cattle of various breeds and ages 4 months to 8 years were tested by HI assay using 0·5% chicken erythrocytes. Virus antigens were back‐titrated at 4 HA units/well. Titers <20 were recorded as negative. HI titers are expressed as geometric means of the positive results (i.e. negative results are excluded from the calculation). As controls, sera from two horses with known exposure to H3N8 equine influenza virus (EIV) were tested against the same antigens, with means and ranges as follows: Equine/KY/94, mean 224 (range 80–640); Swine/TX/98, mean 40 (range 10–160).

EIV replication in primary cultivated bovine nasal turbinate cells

Primary cultures of respiratory epithelial cells are believed to be a useful model for the study of virus–host interactions, 15 , 16 possibly more representative of natural infection than virus culture in embryonated chicken eggs and continuous cell lines, where adaption and passage of influenza virus can change native virus properties such as receptor binding or tissue tropism. 17 , 18 To establish cell growth, we isolated nasal turbinate from a freshly deceased cow, and the bovine turbinate (BT) cells were obtained by proteolysis using similar procedures as reported previously. 19 Primary cultivated BT cells were infected with influenza A/equine/Miami/63 (H3N8) virus at a multiplicity of infection (MOI) of approximately 10 EID50/cell. Tissue culture supernatants from the infected cultures were collected at 24‐hour intervals post‐infection (p.i.) for the analysis of virus infection kinetics by HA and EID50 assays as described previously. 20 EIV HA antigen present in infected cells was detected by indirect immunofluorescent antibody (IFA) staining with a mouse monoclonal antibody (F90 5H1.25, kindly provided by Dr. Judith Appleton) specific for H3N8 EIV surface HA antigen 21 and Texas‐Red conjugated goat anti‐mouse immunoglobulin as the detection antibody. The cytotoxic effect of EIV on BT cells was evaluated by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide (MTT) cell survival assay that is dependent on the cellular reduction of MTT by the mitochondrial dehydrogenase of viable cells to blue formazan product. The conversion (yellow to blue) takes place only in living cells, and the amount of formazan produced is proportional to the number of cells present. 22

Mock‐infected BT cells showed almost no morphologic changes (Figure 1A), whereas EIV‐infected cells at 48 hours p.i. showed cytopathic effect characterized by cell shrinkage, rounding, and detachment from the culture matrix (Figure 1B). By indirect IFA labeling, in comparison with mock‐infected cultures (Figure 1C), a strong fluorescence staining was observed in EIV‐infected cells (Figure 1D). Therefore, BT cells were susceptible to infection by EIV. As shown in Figure 2A, viral HA and EID50 titers were found to rise steadily over 72 hours p.i. from being undetectable to an HA titer of 32 and 2 × 106 EID50 units/ml. These data indicate that EIV not only infected but also actively replicated in BT cells. When cell survival was assessed by MTT assay (Figure 2B), the optical density (OD) in mock‐infected BT cell cultures increased gradually through 72 hours p.i., indicating that the cells continued to proliferate, whereas EIV infection of BT cells caused >50% reduction in OD value at 72 hours p.i. Comparison of Figure 2A and Figure 2B shows that the OD value dropped as the virus yield increased, indicating that the decline in cell survival was associated with virus replication in BT cells and probably resulted from EIV‐mediated apoptotic cell death as we have previously described in equine primary nasal turbinate cells 19 as well as MDCK cells. 23 , 24 Primary equine turbinate cells 19 were susceptible to the infection with the supernatant collected from EIV‐infected BT cell culture (data not shown), showing that the host specificity of BT‐passaged EIV retained infectivity for equine cells.

Figure 1.

Figure 1

 (A and B) Light microscopic appearance of morphological changes and (C and D) indirect IFA staining of mock (−EIV (equine influenza virus), A and C) or virus (+EIV, B and D)‐infected BT cells. Cells were either mock infected with normal egg allantoic fluid alone or infected with EIV (Miami/63, H3N8) and examined at 48 hours p.i. IFA was carried out using a monoclonal antibody against the viral HA. 21

Figure 2.

Figure 2

 (A) Replication of equine influenza virus (EIV) (Miami/63, H3N8) in primary BT cells. Supernatants from infected cells were collected for virus titration at 0, 24, 48, and 72 hour p.i. Virus titers are shown as HA units (dotted line, left scale) and EID50 units (solid line, right scale). (B) Cytocidal effect of EIV on BT cells. Viability of mock (hatched)‐infected and EIV (solid)‐infected BT cells were determined by MTT assay at the same time intervals p.i. as for (A). Data are means ± SD for three cultures.

Experimental infection of calves with EIV

As virus growth in primary cell culture may not correlate with the capability of EIV to infect and cause disease in the intact animal, in vivo experimental infection of live cattle was performed. Briefly, a group of six beef calves (6 months age) and two ponies (8 months age) that were seronegative for EIV were experimentally infected with aerosolized virus strain influenza A/equine/Kentucky/91 (H3N8) as previously described. 25 Each animal was exposed to 106 EID50 of virus by inhalation through a mask. The ponies served as positive infection controls and were housed in a separate stall but in the same room as the calf stalls and were challenged at the same time. The animals were monitored daily for clinical manifestation of influenza, and their rectal temperatures were recorded. As shown in Figure 3, aerosol‐infected calves showed no pyrexia or overt clinical signs, whereas ponies exhibited typical influenza‐like symptoms including pyrexia on Day +2 post‐challenge, nasal discharge, and cough on multiple days later post‐challenge. Nasopharyngeal swabs were collected daily from all animals and were tested for virus shedding by inoculation into embryonated chicken eggs. EIV was detected only in the nasopharyngeal swabs from the positive control ponies, whereas no virus was detected in any of the swabs from the experimentally infected calves (Table 2). Sera were collected and tested by hemagglutination‐inhibition for antibodies against equine/KY/91 virus as described. 14 , 25 As shown in Table 3, both ponies seroconverted following EIV infection, while calves did not. Therefore, live calves were not susceptible to infection with EIV based on standard clinical, virological, or serological measures.

Figure 3.

Figure 3

 Daily rectal temperatures of calves (solid lines, n = 6) and ponies (hatched lines, n = 2) following experimental infection with influenza A/equine/KY/91 virus. Each line represents one animal.

Table 2.

 Virus shedding in nasopharyngeal swabs

Day post‐infection
0 1 2 3 4 5 6 7 8
Calves (ID#)
 #72
 #74
 #76
 #113
 #121
 #139
Ponies (ID#)
 #9929 + + + + + + +
 #9954 + + + + + + +

Nasopharyngeal swabs collected from calves and ponies were inoculated into embryonated chicken eggs and incubated for 3 days at 35°C. Virus growth +/− was determined for each swab by HA assay.

Table 3.

 Serological responses to experimental influenza infection

Day 0 Day +9 Day +20
Calves (ID#)
 72 <10 <10 <10
 74 <10 <10 <10
 76 <10 <10 <10
 113 <10 <10 <10
 121 <10 <10 <10
 139 <10 <10 <10
Ponies (ID#)
 9929 <10 320 320
 9954 <10 160 320

Sera were collected on the indicated days post‐challenge and treated with trypsin‐periodate to remove non‐specific inhibitors of hemagglutination, then assayed by HI assay using intact equine/KY/91 virus as antigen. <10, lower limit of detection.

We observed during the pre‐challenge phase that the beef calves had a higher normal body temperature (mean 38·9°C) than the ponies (37·9°C) (Figure 3). We thank Dr. Alicia Solorzano for the suggestion that this difference in normal body temperature could be critical for in vivo infection if equine/KY/91 virus were temperature‐sensitive. Youngner et al. 26 have previously described the cold‐adaptation of this EIV strain and observed that the wild‐type virus produced titers at 39·5°C (1·5 × 106 PFU/ml) that were within 1 log of those produced at 34°C (1 × 107 PFU/ml). This suggests that 38·9°C should still have been a permissive temperature. Furthermore, the temperature of the upper respiratory tract in both calves and ponies is expected to be slightly less than rectal temperature. Therefore, it seems unlikely that the 1°C difference in core body temperature alone was responsible for the suppression of detectable virus replication in beef calves, although it might have been a contributing factor.

In summary, we demonstrated productive infection of H3N8 EIV in primary cultured bovine respiratory cells. However, H3N8 EIV did not detectably replicate, produce disease, or trigger seroconversion in live beef calves. A serological survey suggests that some bovines in the state of Kentucky were exposed to H3 influenza. It is unclear which H3 viruses were responsible for bovine seroconversion to H3 influenza in the field.

Acknowledgments

We thank Dr. Judith Appleton (Cornell University) for the gift of hybridoma cell lines; Dr. Alicia Solorzano (University of Maryland) for helpful discussion; Drs. Brian Larson and R. B. Hightshoe (Department of Animal & Food Sciences, University of Kentucky) for providing the beef calves; Dr. Udeni Balasuriya, Ms. Zhengchun Lu, Ms. Lynn Tudor, and Ms. Stephanie Reedy for laboratory technical assistance; Ms. Diane Furry for graphics assistance; and Ms. Melissa Britt for maintenance of the animals. This work was carried out in conjunction with a project of the Kentucky Agricultural Experiment Station (USDA/CSREES Project No. KY014028) and is published with approval of the Director (manuscript number 10‐14‐051).

References

  • 1. Brown IH, Crawshaw TR, Harris PA, Alexander DJ. Detection of antibodies to influenza A virus in cattle in association with respiratory disease and reduced milk yield. Vet Rec 1998; 143:637–638. [PubMed] [Google Scholar]
  • 2. Crawshaw TR, Brown I. Bovine influenza. Vet Rec 1998; 143:372. [PubMed] [Google Scholar]
  • 3. Crawshaw TR, Brown IH, Essen SC, Young SC. Significant rising antibody titres to influenza A are associated with an acute reduction in milk yield in cattle. Vet J 2008; 178:98–102. [DOI] [PubMed] [Google Scholar]
  • 4. Gunning RF, Brown IH, Crawshaw TR. Evidence of influenza A virus infection in dairy cows with sporadic milk drop syndrome. Vet Rec 1999; 145:556–557. [DOI] [PubMed] [Google Scholar]
  • 5. Jones‐Lang K, Ernst‐Larson M, Lee B, Goyal SM, Bey R. Prevalence of influenza A virus (H1N1) antibodies in bovine sera. New Microbiol 1998; 21:153–160. [PubMed] [Google Scholar]
  • 6. Lopez JW, Woods GT. Epidemiological study of swine influenza virus as a component of the respiratory disease complex of feeder calves. Res Commun Chem Pathol Pharmacol 1986; 51:417–420. [PubMed] [Google Scholar]
  • 7. Lopez JW, Woods GT. Influenza virus in ruminants: a review. Res Commun Chem Pathol Pharmacol 1984; 45:445–462. [PubMed] [Google Scholar]
  • 8. Graham DA, Calvert V, McLaren E. Retrospective analysis of serum and nasal mucus from cattle in Northern Ireland for evidence of infection with influenza A virus. Vet Rec 2002; 150:201–204. [DOI] [PubMed] [Google Scholar]
  • 9. Campbell CH, Easterday BC, Webster RG. Strains of Hong Kong influenza virus in calves. J Infect Dis 1977; 135:678–680. [DOI] [PubMed] [Google Scholar]
  • 10. Lopez JW, Woods GT. Response of calves to exposure with swine influenza virus. Am J Vet Res 1987; 48:1264–1268. [PubMed] [Google Scholar]
  • 11. Kalthoff D, Hoffmann B, Harder T, Durban M, Beer M. Experimental infection of cattle with highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 2008; 14:1132–1134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Daly JM, Lai AC, Binns MM, Chambers TM, Barrandeguy M, Mumford JA. Antigenic and genetic evolution of equine H3N8 influenza A viruses. J Gen Virol 1996; 77:661–671. [DOI] [PubMed] [Google Scholar]
  • 13. Crawford PC, Dubovi EJ, Castleman WL et al. Transmission of equine influenza virus to dogs. Science 2005; 310:482–485. [DOI] [PubMed] [Google Scholar]
  • 14. OIE Biological Standards Commission . Equine Influenza (ch. 2.5.5); in: OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 5th edn Paris: Office International des Epizooties, 2004; 686–697. [Google Scholar]
  • 15. Endo Y, Carroll KN, Ikizler MR, Wright PF. Growth of influenza A virus in primary, differentiated epithelial cells derived from adenoids. J Virol 1996; 70:2055–2058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. O’Niell FD, Issel CJ. Growth kinetics of equine respiratory tract viruses in cell and organ cultures. Am J Vet Res 1984; 45:1961–1966. [PubMed] [Google Scholar]
  • 17. Hardy CT, Young SA, Webster RG, Naeve CW, Owens RJ. Egg fluids and cells of the chorioallantoic membrane of embryonated chicken eggs can select different variants of influenza A (H3N2) viruses. Virology 1995; 211:302–306. [DOI] [PubMed] [Google Scholar]
  • 18. Schild GC, Oxford JS, De Jong JC, Webster RG. Evidence for host‐cell selection of influenza virus antigenic variants. Nature 1983; 303:706–709. [DOI] [PubMed] [Google Scholar]
  • 19. Lin C, Holland RE Jr, Williams NM, Chambers TM. Cultures of equine respiratory epithelial cells and organ explants as tools for the study of equine influenza virus infection. Arch Virol 2001; 146:2239–2247. [DOI] [PubMed] [Google Scholar]
  • 20. Burleson FG, Chambers TM, Wiedbrauk DL. Virology: A Laboratory Manual. San Diego: Academic Press, 1992. [Google Scholar]
  • 21. Appleton JA, Antczak DF, Lopes AD. Characterization of the equine influenza virus H3 with monoclonal antibodies. Arch Virol 1987; 94:339–346. [DOI] [PubMed] [Google Scholar]
  • 22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55–63. [DOI] [PubMed] [Google Scholar]
  • 23. Lin C, Holland RE Jr, Donofrio JC, McCoy MH, Tudor LR, Chambers TM. Caspase activation in equine influenza virus induced apoptotic cell death. Vet Microbiol 2002; 84:357–365. [DOI] [PubMed] [Google Scholar]
  • 24. Lin C, Zimmer SG, Lu Z, Holland RE Jr, Dong Q, Chambers TM. The involvement of a stress‐activated pathway in equine influenza virus‐mediated apoptosis. Virology 2001; 287:202–213. [DOI] [PubMed] [Google Scholar]
  • 25. Chambers TM, Holland RE, Tudor LR et al. A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge. Equine Vet J 2001; 33:630–636. [DOI] [PubMed] [Google Scholar]
  • 26. Youngner JS, Whitaker‐Dowling P, Chambers TM, Rushlow KE, Sebring R. Derivation and characterization of a live attenuated equine influenza vaccine virus. Am J Vet Res 2001; 62:1290–1294. [DOI] [PubMed] [Google Scholar]

Articles from Influenza and Other Respiratory Viruses are provided here courtesy of Wiley

RESOURCES